BioCryst Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 90   

Articles published

BCRX 5.27 0.00 (0.00%)
price chart
Stock Volatility Risk Alert: BioCryst Pharmaceuticals Inc Realized Volatility ...
Before we cover the full analysis we make a quick alert here that BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) has seen its stock price whip around at an escalated level.
BioCryst Pharmaceuticals Inc. (BCRX) Plunges 9.04% on September 12
BioCryst Pharmaceuticals Inc. (BCRX) had a rough trading day for Tuesday September 12 as shares tumbled 9.04%, or a loss of $-0.52 per share, to close at $5.23.
BioCryst Pharmaceuticals, Inc. (BCRX) Downgraded by ValuEngine  The Ledger Gazette
Insider HUTSON NANCY J bought 1960 Shares Of BioCryst Pharmaceuticals, Inc ...  Economic News
What Stance Are Analysts Taking on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)?
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) currently has an Average Broker Rating of 1.56. This number is based on the 9 sell-side firms polled by Zacks.
Healthcare Sector Stock Notable Movers BioCryst Pharmaceuticals, Inc. (NASDAQ ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) exchanged hands 1,873,620 shares versus average trading capacity of 1.34M shares, while its relative trading volume is 1.41.
BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win
Shares of BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) saw a handy gain on Tuesday after the company released the final results from its mid-stage APeX-1 clinical trial in hereditary angioedema (HAE).
BioCryst Pharma's HAE candidate BCX7353 successful in mid-stage study ...  Seeking Alpha
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Sees Unusual Trading Volume in ...
Here is a rundown on some insider market activity for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Fred E. Cohen, Director disclosed the sale of 54,250 shares.
+DI Over -DI on Shares of BioCryst Pharmaceuticals Inc (BCRX)
Zooming in closer on shares of BioCryst Pharmaceuticals Inc (BCRX), we have noted that the Plus Directional Indicator is currently above the Minus Directional Indicator.
What's Behind BioCryst Pharmaceuticals Inc (BCRX)'s Movement
Shares of BioCryst Pharmaceuticals Inc (BCRX) is moving on volatility today 1.52% or 0.08 from the open. The NASDAQ listed company saw a recent bid of 5.345 on 6294036 volume.
BioCryst Pharmaceuticals Inc. (BCRX) Plunges 5.18% on August 25
BioCryst Pharmaceuticals Inc. (BCRX) had a rough trading day for Friday August 25 as shares tumbled 5.18%, or a loss of $-0.25 per share, to close at $4.58.
BioCryst to Present at Three Upcoming Investor Conferences  Nasdaq
Drilling Down Into the Books for BioCryst Pharmaceuticals, Inc. (BCRX)  StockNewsGazette
Why to Keeping Eye on BioCryst Pharmaceuticals, Inc. (BCRX), Huntington ...
BioCryst Pharmaceuticals, Inc. (BCRX) have shown a high EPS growth of 9.90% in the last 5 years and has earnings decline of -26.80% yoy.